The U.S. pharmaceutical industry is pushing to revamp the new law that allows Medicare to negotiate prices for its costliest ...
Millions of Americans with obesity would be eligible to have popular weight-loss drugs like Wegovy or Ozempic covered by ...
The U.S. pharmaceutical industry is pushing to revamp the new law that allows Medicare to negotiate prices for its costliest ...
Joe Biden wants diabetes drugs that aid weight loss and treat obesity, such as Wegovy, to fall under Medicare and Medicaid.
The Biden administration proposed a rule for Medicare and Medicaid to cover the costs of weight-loss drugs for millions of ...
More than seven million additional Americans could get coverage for popular drugs such as Zepbound and Wegovy under the ...
Medicare and Medicaid would be required to cover weight loss drug prescriptions for millions of obese Americans under plans ...
Changes to Medicare in 2025 include a cap on out-of-pocket prescription drug costs, changes to mental health care services, ...
2h
The CMS estimated that coverage of the weight-loss drugs will cost the federal government about $25 billion for Medicare and ...
Medicare's star ratings system also accounts for enrollee turnaround. A plan that loses a lot of members in a given year will ...
The Biden administration proposed a rule to let Medicare and Medicaid cover obesity drugs like Ozempic. Millions would ...
A record-low number of Medicare Part D plans could cause greater Medicare Advantage enrollment, which may not be a good thing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback